StonvexLoading…
StonvexStonvexStonvexCore line items from SHLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $475.33M | $399.21M | $488.94M | $326.94M |
Operating Income | $56.38M | $51.17M | $79.03M | $66.33M |
Net Income | $33.57M | $24.13M | $39.97M | $127.61M |
EPS (Diluted) | $0.20 | $0.14 | $0.24 | $0.85 |
Total Assets | $904.10M | $793.08M | $843.99M | $594.89M |
Total Liabilities | $304.13M | $236.28M | $299.00M | $293.91M |
Cash & Equivalents | $7.32M | $23.51M | $22.71M | $8.77M |
Free Cash Flow OCF − CapEx | $-15.98M | $72.00M | $81.38M | $36.30M |
Shares Outstanding | 168.38M | 168.72M | 164.50M | 167.63M |